The company is attempting to lower its $30 billion in accrued debts.
Here is what you need to know.
1. Valeant shares closed Jan. 9, 2017 at $15.35 and opened the following day at $17.12 following the acquisition news.
2. The company ended its day at $16.42. As of 11 a.m. EST, Jan. 11, 2017, Valeant was trading at $16.26.
3. Valeant’s 52-week range is between $13 and $101.40.
4. The company has a market cap of $5.93 billion.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Bradley Zins of the Billings Clinic
ASGE certifies Mercy Hospital: 3 things to know
Dr. Brian Davis hosts video on The Fundamentals of Endoscopic Surgery exam
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
